首页> 美国卫生研究院文献>Journal of Diabetes Science and Technology >Detection of 15-Anhydroglucitol by Electrochemical Impedance Spectroscopy
【2h】

Detection of 15-Anhydroglucitol by Electrochemical Impedance Spectroscopy

机译:电化学阻抗谱法检测15-脱水葡萄糖醇

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Multiple markers are used to assess glycemic control in patients with diabetes mellitus (DM). New technology that permits simultaneous detection of multiple biomarkers combined with those used at the point of care indicative of glycemic control, including glycemic variability determined from 1,5-anhydroglucitol measurement, could provide better management and further insight into the disease. This platform was based on previous research involving glucose detection and uses electrochemical impedance spectroscopy to detect a range of 1,5-anhydroglucitol concentrations at an optimal binding frequency. The enzyme pyranose oxidase was fixed to gold electrodes while a sine wave of sweeping frequencies was induced in purified solutions and in variable presence of whole blood. The optimal binding frequency for the detection of 1,5-anhydroglucitol was found to be 3.71 kHz. The impedance response compared to the concentration of target present was found to have a logarithmic slope of 7.04 with an R-squared value of 0.96. This response includes 2 experimental sets, a single test of a low concentration range and a high concentration range with 5 replicates. The relative standard deviation of the high range varied from 28% to 27% from lowest to highest concentrations. Best detection in complex solutions was found in lower blood concentrations of 0.5% and 1%, but maintained relatively high accuracy in concentrations 5% and 10%. The sensor platform was successfully evaluated at a high dynamic range of 1,5-AG in purified solutions. In the presence of whole blood, lowest percentages yielded the best results indicating that filtering interferents may be necessary in final device architecture.
机译:多种标记物用于评估糖尿病(DM)患者的血糖控制。允许同时检测多种生物标志物以及在指示血糖控制的护理点使用的那些生物标志物的新技术,包括通过1,5-脱水葡萄糖醇测量确定的血糖变异性,可以提供更好的管理和对疾病的进一步了解。该平台基于先前涉及葡萄糖检测的研究,并使用电化学阻抗光谱法以最佳结合频率检测一定范围的1,5-脱水葡萄糖醇浓度。吡喃糖氧化酶固定在金电极上,同时在纯溶液和全血存在下诱发扫描频率的正弦波。发现用于检测1,5-脱水葡萄糖醇的最佳结合频率是3.71kHz。与存在的靶标浓度相比,阻抗响应被发现具有7.04的对数斜率,R-平方值是0.96。该响应包括2个实验组,一次低浓度范围和高浓度范围的测试,重复5次。高范围的相对标准偏差从最低到最高浓度从28%到27%不等。在较低浓度的0.5%和1%的血液中发现了在复杂溶液中的最佳检测结果,但是在5%和10%的浓度下却保持了较高的准确度。在高动态范围的1,5-AG纯化溶液中成功评估了传感器平台。在存在全血的情况下,最低的百分比会产生最佳的结果,表明在最终的设备架构中可能需要过滤干扰物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号